Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 24, 2007

Averion Expands CRO Services into Brazil

  • Averion and Biocancer, two clinical research organizations (CROs), will jointly market and contract complementary services to biotechnology, pharmaceutical, and medical device companies.

    Biocancer is based in Brazil and focuses on oncology. “This agreement expands our reach to South America, providing us with access to leading clinical sites and large patient populations,” points out Philip Lavin, Ph.D., Averion's CEO. “We plan to continue building on our international oncology CRO offering through strategic partnerships and acquisitions.”



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »